Details for Patent: 8,715,623
✉ Email this page to a colleague
Summary for Patent: 8,715,623
Title: | Pulmonary delivery of aminoglycoside |
Abstract: | A dispersible powder composition comprises aminoglycoside for delivery to the lungs. The composition is effective to provide a therapeutically effective therapy via administration of less than 6 respirable unit doses by inhalation, wherein each unit dose comprises a volume of 0.30 to 0.95 mL. |
Inventor(s): | Tarara; Thomas E. (Burlingame, CA), Weers; Jeffry G. (Half Moon Bay, CA), Venthoye; Geraldine (Foster City, CA) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 11/981,986 |
Patent Claim Types: see list of patent claims | Composition; Compound; Delivery; Dosage form; Use; Device; |
Drugs Protected by US Patent 8,715,623
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,715,623
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 508735 | ⤷ Sign Up | |||
Australia | 2002361897 | ⤷ Sign Up | |||
Canada | 2468958 | ⤷ Sign Up | |||
Cyprus | 1112560 | ⤷ Sign Up | |||
Denmark | 1458360 | ⤷ Sign Up | |||
European Patent Office | 1458360 | ⤷ Sign Up | |||
Spain | 2364636 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |